3.92
-0.06(-1.51%)
Currency In USD
| Previous Close | 3.98 |
| Open | 3.92 |
| Day High | 4.11 |
| Day Low | 3.77 |
| 52-Week High | 5.98 |
| 52-Week Low | 2.2 |
| Volume | 716,701 |
| Average Volume | 231,795 |
| Market Cap | 221.34M |
| PE | -2.18 |
| EPS | -1.8 |
| Moving Average 50 Days | 4.24 |
| Moving Average 200 Days | 3.41 |
| Change | -0.06 |
If you invested $1000 in Orchestra BioMed Holdings, Inc. (OBIO) since IPO date, it would be worth $343.86 as of February 21, 2026 at a share price of $3.92. Whereas If you bought $1000 worth of Orchestra BioMed Holdings, Inc. (OBIO) shares 5 years ago, it would be worth $282.22 as of February 21, 2026 at a share price of $3.92.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
GlobeNewswire Inc.
Jan 12, 2026 2:00 PM GMT
$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnoutsVivasure Medical Limited (“Vivasure”) has been a strategic holding of Orchestra BioMed since the Company’s forma
Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
GlobeNewswire Inc.
Dec 08, 2025 12:00 PM GMT
Joint presentation by Orchestra BioMed and Medtronic leadership to discuss ongoing strategic collaboration for development and commercialization of AVIM Therapy for treatment of uncontrolled hypertension in patients indicated for a pacemaker NEW HOPE
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Nov 26, 2025 9:05 PM GMT
NEW HOPE, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market